Table 3 Sensitivity analysis of associations between APOE alleles and MI risks
Study | ε2 | ε4 |
|---|---|---|
Cumming et al | 0.73 (0.68, 0.78) | 1.13 (1.08, 1.19) |
Yamamura et al | 0.76 (0.71, 0.82) | 1.16 (1.10, 1.23) |
Utermann et al | 0.76 (0.71, 0.82) | 1.16 (1.10, 1.23) |
Lenzen et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.21) |
Luc et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.20) |
Luc et al | 0.74 (0.69, 0.79) | 1.14 (1.09, 1.20) |
Luc et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Luc et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Joven et al | 0.72 (0.67, 0.77) | 1.13 (1.07, 1.19) |
Nakai et al | 0.73 (0.68, 0.78) | 1.13 (1.08, 1.19) |
Batalla et al | 0.73 (0.69, 0.79) | 1.14 (1.08, 1.20) |
Zhao et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Raslová et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Wang et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.20) |
Gong et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Bai et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Kolovou et al | 0.73 (0.68, 0.78) | 1.13 (1.08, 1.19) |
Mamotte et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Kumar et al | 0.73 (0.68, 0.78) | 1.13 (1.07, 1.19) |
Li et al | 0.73 (0.68, 0.78) | 1.13 (1.08, 1.20) |
Chen et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.20) |
Keavney et al | 0.69 (0.63, 0.75) | 1.14 (1.07, 1.22) |
Ranjith et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.20) |
Aasvee et al | 0.73 (0.68, 0.79) | 1.14 (1.08, 1.20) |
Baum et al | 0.74 (0.69, 0.80) | 1.13 (1.08, 1.19) |
Koch et al | 0.71 (0.66, 0.77) | 1.16 (1.09, 1.22) |
Viitanen et al | 0.73 (0.68, 0.78) | 1.13 (1.08, 1.19) |
Onrat et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Tanguturi et al | 0.73 (0.68, 0.78) | 1.13 (1.07, 1.19) |
Kukava et al | 0.73 (0.68, 0.78) | 1.15 (1.09, 1.21) |
Gupta et al | 0.73 (0.68, 0.78) | 1.14 (1.08, 1.20) |
Hu et al | 0.74 (0.69, 0.79) | 1.15 (1.09, 1.21) |